INFORMATION BY CANCER TYPE

Leukemia

Seeking a Complete Response in Hematologic Cancers
BY Jason Harris
Experts discuss how to have the best chances for a complete response for patients with chronic lymphocytic leukemia (CLL) who developed Hodgkin lymphoma (HL). 
FDA Approves Rydapt for AML
BY Jason M. Broderick
The Food and Drug Administration has approved Rydapt (midostaurin) for acute myeloid leukemia (AML).
Waiting for the Next Breakthrough: Living With a Chronic Blood Cancer
BY Tara Haelle
"Neither feels guilty about surviving — although both have had plenty of reminders that they’re dealing with cancer — and both have found ways to continue enjoying life." 
A New Formulation for Rituxan Moves Ahead With FDA Committee Vote
BY Jason M. Broderick
All members of the FDA’s Oncologic Drugs Advisory Committee (ODAC) voted to approve Rituxan for the treatment of some blood cancers.
Looking Ahead: What's New In CAR T-Cell Therapy for Hematologic Malignancies
BY Rebecca Bernaski
Jim Kochenderfer, M.D., lends insight to the future of CAR T-cell therapy for hematologic malignancies.
Debunking the Myths of Stem Cell Donation
BY Allie Casey
Just one person can make a difference for patients with blood cancer.
A New Chapter Begins With CML
BY Tara Haelle
Hope is growing for patients who are living with CML. 
Blincyto Improves Survival for Ph- Relapsed Acute Lymphoblastic Leukemia
BY Jason M. Broderick
In a recent study, Blincyto (blinatumomab) had longer survival rates than standard chemotherapy for certain patients with ALL. 
The Final Chemo Cycle
BY Edward McClain
As Ed completes his final chemo cycle, he loses a friend.
Vyxeos Helps More Patients With AML Proceed to Transplant
BY Silas Inman
More people with AML who were treated with Vyxeos were moved to transplant than those treated with a standard chemotherapy regimen, according to recent findings.
Special Feature
Share Your Art
Talk about this article with other patients, caregivers, and advocates in the Leukemia CURE discussion group.
Search Cancer Drugs & Terms
Treatment
Information about treatment, including surgery, chemotherapy, radiation therapy, immunotherapy, and vaccine therapy
Adult Acute Lymphoblastic Leukemia Treatment (PDQ®)
Expert-reviewed information summary about the treatment of adult acute lymphoblastic leukemia.
Adult Acute Myeloid Leukemia Treatment (PDQ®)
Expert-reviewed information summary about the treatment of adult acute myeloid leukemia.
Childhood Acute Lymphoblastic Leukemia Treatment (PDQ®)
Expert-reviewed information summary about the treatment of childhood acute lymphoblastic leukemia.
Chronic Lymphocytic Leukemia Treatment (PDQ®)
Expert-reviewed information summary about the treatment of chronic lymphocytic leukemia.
Chronic Lymphocytic Leukemia Treatment (PDQ®)
Expert-reviewed information summary about the treatment of chronic lymphocytic leukemia.
Chronic Myelogenous Leukemia Treatment (PDQ®)
Expert-reviewed information summary about the treatment of chronic myelogenous leukemia.
Hairy Cell Leukemia Treatment (PDQ®)
Expert-reviewed information summary about the treatment of hairy cell leukemia.
x